Groupe SNPE is seeking a buyer for its Isochem fine chemicals business. SNPE expects the sale to be completed within six to eight months.
SNPE
Sunday, 5 July 2009
Buyer sought for Isochem
Subscribe to:
Post Comments (Atom)
skip to main |
skip to sidebar
NEWS AND VIEWS FROM THE PHARMACEUTICAL FINE CHEMICAL AND CUSTOM MANUFACTURING SECTOR
Fine
The FINE blog keeps you up-to-date on the pharmaceutical fine chemical and custom manufacturing sector. The weekly FINE Newsletter gives senior pharmaceutical fine chemical and custom manufacturing leaders a weekly summary of the key news stories and trends for the sector. The FINE Newsletter and blog focus on coverage of companies in the pharmaceutical fine chemical custom manufacturing sector, without forgetting key news from their customers in the pharma industry.
Subscribe
To receive the newsletter, each week, please subscribe.
Advertising
|
|
|
|
||
| Read this FREE online! Full Book | PDF Summary | Podcast | ||
Blog Archive
-
▼
2009
(368)
-
▼
July
(28)
- SAFC Pharma has completed the first production run...
- PacificGMP will provide development and manufactur...
- SAFC orders boosted by H1N1
- Albemarle sees fine chemicals income decline 80%
- Cambridge Major to open new API facility
- Lonza's first-half profits declined 33% as a resul...
- Almac receives MHRA licence for GMP radiolabeling ...
- Fine chems first quarter positive for Johnson Matthey
- Lonza consolidates custom manufacturing operations
- The Informex USA show has been rebranded into two ...
- SynCo Bio Partners has increased its capacity thro...
- The Food and Drug Administration hopes to build cl...
- Lonza is being investigated by the Swiss stock exc...
- Lonza will manufacture LFB's anti-RhD antibody
- Senate committee vote on biosimilars
- Genhelix Biopharmaceutical will provide GMP produc...
- Almac starts recruiting as first phase of £9m expa...
- Lonza will provide development and commercialisati...
- Lonza to join Swiss blue-chip index
- Prosonix receives ISO 9001:2008 accreditation
- Lonza converts CHF430m bond into shares
- Hikal has merged its Hikal Pharmaceuticals subsidi...
- Buyer sought for Isochem
- Novasep has acquired Belgian biopharmaceutical CMO...
- Ark Therapeutics will manufacture Lx Therapies vas...
- Lonza in contract dispute with Altus
- Hovione's API plant in Macau has passed an FDA pre...
- Cobra Biomanufacturing saw revenues rise 62%, marg...
-
▼
July
(28)
Technorati
Copyright ©2007, 2008 FINE. All rights reserved.
No comments:
Post a Comment